UPDATED May 18, 2022
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SHLSiemens Healthineers | €55.70 | 7.9% | 21.0% | €62.5b | €67.39 | PS32.9x | E14.2% | 1.5% | ||
SRTSartorius | €313.00 | 7.0% | -13.2% | €22.1b | €443.55 | PS49.3x | E11.1% | 0.4% | ||
FREFresenius SE KGaA | €32.78 | -3.8% | -26.2% | €18.3b | €44.55 | PS10.2x | E10.7% | 2.8% | ||
FMEFresenius Medical Care KGaA | €56.82 | -3.0% | -14.5% | €16.6b | €65.45 | PS19x | E19.2% | 2.4% |